acquired
Stage
1
Investors
About
Orchard Therapeutics develops and commercializes gene therapies primarily for rare immunological, neurological, and genetic disorders.
Explore Orchard Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.